New treatment targeting aging cells could offer lasting relief for diabetic macular edema

Targeting senescent cells in the retina with a BCL-xL inhibitor shows promise as a durable treatment for diabetic macular edema, potentially offering long-term visual function improvements.

Clinical study suggests statins could be key in reducing dementia in individuals with heart failure

The association between statin therapy and the risks of dementia among patients with heart failure.

January 19, 2024

ALPK2 identified as promising new therapeutic target for treatment of heart failure

Tatsuya Yoshida, Mikito Takefuji, and Toyoaki Murohara in the Department of Cardiology, Nagoya University Graduate School of Medicine, identified an enzyme, alpha-kinase 2 (ALPK2) that

January 30, 2025

Phreesia Appoints Jack Callahan as Chief Technology Officer

What You Should Know: – Phreesia, a provider of patient intake, outreach and activation appoints Jack Callahan as the company’s new Chief Technology Officer. –

March 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.